Countries South Korea

Samsung Biologics Secures USD 668 Million in Manufacturing Deals with Europe, Surpasses USD 4 Billion in 2024 Global Contract Value

The company will provide manufacturing services through 2031 in deals worth over USD 668 million Samsung Biologics' cumulative contract value for 2...

 November 20, 2024 | News

Lunit and AstraZeneca Collaborate in South Korea to Transform Lung Cancer Diagnostics with AI-Powered Genotype Predictor

Collaboration to harness Lunit SCOPE Genotype Predictor for rapid and convenient prediction of non-small cell lung cancer driver mutations Lunit (KRX:3281...

 November 19, 2024 | News

Everest Medicines' NEFECON® Gains Full Approval in South Korea for IgA Nephropathy Treatment

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing an...

 November 19, 2024 | News

SK Biopharmaceuticals Partners with KIRAMS to Advance Radiopharmaceutical Cancer Therapies Using Actinium-225

SK Biopharmaceuticals, Korea Institute of Radiological and Medical Sciences collaborate on discovering and developing radiopharmaceutical drug candidates...

 November 19, 2024 | News

South Korea’s Celltrion Acquires iQone Healthcare Switzerland to Boost Direct Commercialization of Biosimilars in Europe

Celltrion announces acquisition of iQone Healthcare Switzerland, accelerating direct commercialization of its biosimilars in the European region T...

 November 18, 2024 | News

DX&VX Selected for South Korea's ARPA-H Project to Pioneer Room-Temperature mRNA Vaccine Storage

Pioneering Korea's ARPA-H Project: Focused on mRNA Vaccine Room-Temperature Storage and Extra-Long-Term Preservation Creating a Platform for Prolonged R...

 November 04, 2024 | News

South Korean Neurophet Partners with LADO to Launch Brain PET Analysis Software in China, Establishes Joint Venture

Neurophet enters into a strategic agreement with LADO to distribute Neurophet SCALE PET Improves the efficiency of market entry with expertise of medica...

 October 31, 2024 | News

Avance Clinical Bolsters Asia-Pacific Presence with Strategic Partnerships in South Korea

Avance Clinical, a leading full-service global Contract Research Organization (CRO), has announced the signing of three pivotal Memorandums of Understandin...

 October 30, 2024 | News

GC Biopharma and Novelty Nobility Join Forces to Develop New Antibody Therapy for Geographic Atrophy in Age-Related Macular Degeneration

GC Biopharma announced that it has signed an agreement with Novelty Nobility, a biotech company specializing in the development of antibody-based therapeut...

 October 29, 2024 | News

South Korea’s Qurient Launches Phase 1 Clinical Trial for Adrixetinib in AML Following FDA IND Clearance

Qurient has announced the commencement of a clinical trial for adrixetinib (formerly named Q702), following the clearance of its investigational new drug (...

 October 25, 2024 | News

Lunit AI Cuts Radiologist Workload by 50% While Predicting Cancer Risk Up to Six Years in Advance, New Studies Show

Two new studies show Lunit INSIGHT MMG cuts radiologist workload by 50% in a double reading environment while maintaining or improving screening qua...

 October 24, 2024 | News

SK bioscience Gains Approval for SKYCellflu in Indonesia, Expanding Global Reach for Cell-Cultured Influenza Vaccines

This approval paves the way for exports to the world's fourth most populous country. SK bioscience aims to continue to grow as a global vaccine brand be...

 October 23, 2024 | News

Thermo Fisher Concludes Successful Bioprocess World Tour 2024 in APJ, Reigniting Industry Momentum Post-COVID

Thermo Fisher Scientific is proud to announce the successful conclusion of its highly anticipated Bioprocess World Tour 2024 in the Asia-Pacific and Japan ...

 October 23, 2024 | News

Angelini Pharma Secures Global and Asia Licensing Option for Brain Health Compound CV-01 in Partnership with Cureverse

The agreement gives Angelini Pharma an option to exclusive licensing rights to develop and commercialize CV-011, a clinical Phase 1 investigational novel...

 October 23, 2024 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close